Page last updated: 2024-09-03

lestaurtinib and Basal Cell Cancer

lestaurtinib has been researched along with Basal Cell Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ashworth, A; Burn, J; Clewes, O; Elliott, R; Langtry, J; Lord, CJ; Mackay, A; Rajan, N; Reis-Filho, JS; Sieber-Blum, M	1

Other Studies

1 other study(ies) available for lestaurtinib and Basal Cell Cancer

Article	Year
Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours. Oncogene, 2011, Oct-13, Volume: 30, Issue:41 Topics: Adenoma, Sweat Gland; Carbazoles; Carcinoma, Adenoid Cystic; Cluster Analysis; Comparative Genomic Hybridization; Deubiquitinating Enzyme CYLD; Furans; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Immunohistochemistry; Mutation; Neoplasms; Neoplasms, Basal Cell; Oligonucleotide Array Sequence Analysis; Primary Cell Culture; Protein Kinases; Receptor, trkB; Receptor, trkC; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Sweat Gland Neoplasms; Tissue Array Analysis; Tumor Cells, Cultured; Tumor Suppressor Proteins	2011

Article

Year

Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours.

Oncogene, 2011, Oct-13, Volume: 30, Issue:41

Topics: Adenoma, Sweat Gland; Carbazoles; Carcinoma, Adenoid Cystic; Cluster Analysis; Comparative Genomic Hybridization; Deubiquitinating Enzyme CYLD; Furans; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Immunohistochemistry; Mutation; Neoplasms; Neoplasms, Basal Cell; Oligonucleotide Array Sequence Analysis; Primary Cell Culture; Protein Kinases; Receptor, trkB; Receptor, trkC; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Sweat Gland Neoplasms; Tissue Array Analysis; Tumor Cells, Cultured; Tumor Suppressor Proteins

2011